Nuevolution A/S
COPENHAGEN - Nuevolution A/S today announced that it has received a milestone payment derived from its collaboration with Merck & Co.
COPENHAGEN, Denmark - Nuevolution today announced the execution of a worldwide technology cross-licensing agreement with GlaxoSmithKline.
COPENHAGEN - Nuevolution A/S today announced that Merck & Co.
